Highbridge Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-46,660
Closed -$2.11M 1194
2017
Q1
$2.07M Buy
46,660
+21,796
+88% +$942K 0.03% 439
2016
Q4
$956K Buy
+24,864
New +$986K 0.02% 555
2015
Q4
Sell
-674,595
Closed -$29.8M 1451
2015
Q3
$27.1M Buy
+674,595
New +$31.8M 0.42% 52
2014
Q4
Sell
-598,140
Closed -$26.1M 1133
2014
Q3
$24.9M Buy
598,140
+34,026
+6% +$1.44M 0.33% 88
2014
Q2
$23.1M Sell
564,114
-35,632
-6% -$1.4M 0.28% 98
2014
Q1
$23.1M Buy
599,746
+593,546
+9,573% +$22.9M 0.29% 94
2013
Q4
$238K Sell
6,200
-1,528,594
-100% -$56.3M ﹤0.01% 929
2013
Q3
$50.9M Buy
1,534,794
+254,775
+20% +$8.94M 0.54% 27
2013
Q2
$44.6M Buy
+1,280,019
New +$46.9M 0.44% 37

Other funds holding ABT

Highbridge Capital Management's ABT Position: Q2 2017 in Review

Highbridge Capital Management sold out of Abbott (ABT) in Q2 2017, closing a stake of 46,660 shares — an estimated $2.11M sold.

Highbridge Capital Management first reported a position in ABT in Q2 2013 and held it in 9 quarters. The position peaked at $50.9M in Q3 2013. 1,576 funds tracked by Wall St. Rank hold ABT as of Q2 2017.

  • Highbridge Capital Management reported no remaining Abbott position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 46,660 Abbott shares in Q2 2017, an estimated $2.11M.
  • Highbridge Capital Management first reported a position in Abbott in Q2 2013 and held it in 9 quarters.
  • Highbridge Capital Management's Abbott position peaked at $50.9M in Q3 2013.
  • 1,576 funds tracked by Wall St. Rank held Abbott as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.